Literature DB >> 2562835

Type 3 fimbriae among enterobacteria and the ability of spermidine to inhibit MR/K hemagglutination.

G F Gerlach1, B L Allen, S Clegg.   

Abstract

The distribution of the gene cluster encoding type 3 fimbriae among various isolates of the family Enterobacteriaceae was investigated by using 112 clinical and nonclinical isolates. Closely related DNA sequences were detected in all Klebsiella strains, in most Enterobacter isolates, in a smaller number of Escherichia coli and Salmonella spp., and in a single isolate each of Yersinia enterocolitica and Serratia liquefaciens but not in isolates of Morganella or Providencia species or Serratia marcescens. Except for E. coli and Salmonella strains, the presence of gene sequences was correlated with the phenotypic expression of either the MR/K hemagglutinin or fimbriae that reacted with specific antibodies. In one isolate of Y. enterocolitica the expression of type 3 fimbriae was plasmid determined. The polyamine spermidine was identified as an inhibitor of MR/K hemagglutinating activity, exhibiting an MIC of 1.2 mM. Spermidine inhibited the hemagglutination of 37 MR/K-positive clinical isolates from various genera. However, one clinical isolate of Enterobacter cloacae and most (four of five) nonclinical Klebsiella isolates were not completely inhibited.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562835      PMCID: PMC313073          DOI: 10.1128/iai.57.1.219-224.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Antigenic relationships among type-3 fimbriae of Enterobacteriaceae revealed by immunoelectronmicroscopy.

Authors:  D C Old; R A Adegbola
Journal:  J Med Microbiol       Date:  1985-08       Impact factor: 2.472

2.  Multiple fimbrial haemagglutinins in Serratia species.

Authors:  D C Old; R Adegbola; S S Scott
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

3.  Haemagglutinins and fimbriae of Morganella, Proteus and Providencia.

Authors:  D C Old; R A Adegbola
Journal:  J Med Microbiol       Date:  1982-11       Impact factor: 2.472

4.  Complementation and regulatory interaction between two cloned fimbrial gene clusters of Escherichia coli strain KS71.

Authors:  M Rhen; V Väisänen-Rhen; A Pere; T K Korhonen
Journal:  Mol Gen Genet       Date:  1985

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Construction and comparison of recombinant plasmids encoding type 1 fimbriae of members of the family Enterobacteriaceae.

Authors:  S Clegg; S Hull; R Hull; J Pruckler
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

7.  A comparative study of the type-3 fimbriae of Klebsiella species.

Authors:  D C Old; A Tavendale; B W Senior
Journal:  J Med Microbiol       Date:  1985-10       Impact factor: 2.472

8.  Hemagglutinins of Klebsiella pneumoniae and Klebsiella oxytoca.

Authors:  A Przondo Hessek; G Pulverer
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-11

9.  Carbohydrate specificity of the surface lectins of Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium.

Authors:  N Firon; I Ofek; N Sharon
Journal:  Carbohydr Res       Date:  1983-08-16       Impact factor: 2.104

Review 10.  Clinical relevance of polyamines.

Authors:  D H Russell
Journal:  Crit Rev Clin Lab Sci       Date:  1983       Impact factor: 6.250

View more
  15 in total

1.  Assembly of fimbrial structures in Pseudomonas aeruginosa: functionality and specificity of chaperone-usher machineries.

Authors:  Ségolène Ruer; Silke Stender; Alain Filloux; Sophie de Bentzmann
Journal:  J Bacteriol       Date:  2007-02-09       Impact factor: 3.490

2.  Plasmid content of a clinically relevant Klebsiella pneumoniae clone from the Czech Republic producing CTX-M-15 and QnrB1.

Authors:  Monika Dolejska; Laura Villa; Hana Dobiasova; Daniela Fortini; Claudia Feudi; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

3.  Type 3 fimbriae and biofilm formation are regulated by the transcriptional regulators MrkHI in Klebsiella pneumoniae.

Authors:  Jeremiah G Johnson; Caitlin N Murphy; Jean Sippy; Tylor J Johnson; Steven Clegg
Journal:  J Bacteriol       Date:  2011-05-13       Impact factor: 3.490

4.  Characterization of the type 3 fimbrial adhesins of Klebsiella strains.

Authors:  T A Sebghati; T K Korhonen; D B Hornick; S Clegg
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Fimbrial types among respiratory isolates belonging to the family Enterobacteriaceae.

Authors:  D B Hornick; B L Allen; M A Horn; S Clegg
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

6.  Salmonella typhimurium fimbrial phase variation and FimA expression.

Authors:  S Clegg; L S Hancox; K S Yeh
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

7.  Construction and characterization of a fimZ mutant of Salmonella typhimurium.

Authors:  K S Yeh; L S Hancox; S Clegg
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

8.  The type 3 fimbrial adhesin gene (mrkD) of Klebsiella species is not conserved among all fimbriate strains.

Authors:  T A Schurtz; D B Hornick; T K Korhonen; S Clegg
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression.

Authors:  David A Rosen; Jerome S Pinkner; Jennifer M Jones; Jennifer N Walker; Steven Clegg; Scott J Hultgren
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

10.  Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection.

Authors:  A M Tarkkanen; B L Allen; P H Williams; M Kauppi; K Haahtela; A Siitonen; I Orskov; F Orskov; S Clegg; T K Korhonen
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.